Is everyone hating on GLP-1 meds?

Hong Kong Yanpep International
The pushback peaks when something actually works. This community is the counter to the shortcut narrative.
 
The coverage-denied-for-small-goals bitterness is a real and specific subset of the opposition - it's not ideological, it's personal rejection getting redirected as moral judgment on people who did qualify. The target post is right that the stigma is disproportionate.
 
The GLP-1 stigma versus psychedelic openness inversion is a real social dynamic - one is coded as a shortcut for the lazy while the other has been reframed as consciousness exploration. Neither coding reflects the actual complexity of the substance, but the social reception is completely different.
 
the 'just switch' response from a pharmaceutical company when there's a documented formulation issue is exactly as frustrating as it sounds - switching involves re-titration, adjustment periods, and no guarantee the new product matches what was working. the dismissal of the patient experience in favor of the commercially convenient answer is a real and consistent pattern
 
You must log in or register to reply here.
Back
Top